Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer

Author： Limat Samuel   Bracco-Nolin Claire-Hélène   Legat-Fagnoni Christine   Chaigneau Loic   Stein Ulrich   Huchet Bernard   Pivot Xavier   Woronoff-Lemsi Marie-Christine  

Publisher： Springer Publishing Company

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.7, Iss.2, 2006-06, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary Methionine Restriction with FOLFOX Regimen as First Line Therapy of Metastatic Colorectal Cancer: A Feasibility Study

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 205-209

Karger

Access to resources Recommend Favorite

Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials

By  

Oncology, Vol. 83, Iss. 5, 2012-08 ,pp. : 241-247

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of First-Line Chemotherapies in Metastatic Colorectal Cancer

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

First-Line Treatment with Irinotecan and Raltitrexed in Metastatic Colorectal Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 58-63

Karger

Access to resources Recommend Favorite

Response to Reintroduction of Cetuximab in 5 Patients with Advanced, Chemotherapy-Resistant, Colorectal Cancer without Progressive Disease following First-Line Therapy with a Cetuximab-Containing Regimen

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 123-126

Karger

Access to resources Recommend Favorite